NGM Biopharmaceuticals

NGM Biopharmaceuticals

A clinical-stage biopharmaceutical company which engages in the discovery and development of novel therapeutics for the treatment of cardio-metabolic, liver, oncologic, and ophthalmic diseases.

Launch date
Employees
Market cap
€117m
Enterprise valuation
(€33m) (Public information from Apr 2024)
South San Francisco California (HQ)
Authorizing premium user...